By Canadian Press

Canada signs deals with Pfizer, Moderna to get doses of COVID-19 vaccines

Aug 5, 2020 | 8:17 AM

OTTAWA — Canada is signing deals with pharmaceutical giant Pfizer and U.S.-based biotech firm Moderna to procure millions of doses of their experimental COVID-19 vaccines.

Procurement Minister Anita Anand is announcing the deals this morning in Toronto, which will see Canada get access to the vaccines if they prove to be both safe and effective.

Both companies began Phase 3 clinical trials of their vaccine candidates in the last week, large-scale tests to determine how well the vaccines work.

Earlier in July both Pfizer and Moderna reported positive results from smaller trials.

The Phase 3 trials will both test the vaccines on 30,000 people, and results are expected in the fall.

Nighttime construction on Hwy 3 in Lethbridge starts April 17

Apr 17, 2025

SASHA launches #BuyABed fundraiser to support vulnerable Lethbridge residents

Apr 04, 2025

$20K grants available: TELUS STORYHIVE Pan-Asian Edition opens applications April 1

Mar 18, 2025

Canada’s chief public health officer Dr. Theresa Tam warned Tuesday about expecting a vaccine to provide a quick end to the pandemic, saying they provide hope but likely no silver bullet for the novel coronavirus.

This report by The Canadian Press was first published Aug. 5, 2020.

The Canadian Press

For local news delivered daily to your email inbox, subscribe for free to the Lethbridge News Now newsletter here. You can also download the Lethbridge News Now mobile app in the Google Play and the Apple App Stores.